The conjugation of HBED-CC enabled the research group to produce highly-specific activities of 68Ga-DKFZ-PSMA-11 [21] and clinical experience show that the degree of accuracy of 68Ga-DKFZ-PSMA-11 PET/CT will have a huge impact on the management of patients with PC and will address an important unmet need in this field [22]. This evidence concerns the gene FOLH1 and pachyonychia congenita.